Subject must be able to give written Institutional Review Board (IRB) approved informed consent and be able to follow protocol requirements
Patients must give IRB approved, study specific, informed consent.
Able to and provides Institutional Review Board (IRB) approved study specific written informed consent
Eligible and consent to the Institutional Review Board (IRB) - registry trial protocol
Patients must sign IRB approved study specific informed consent.
Patients must sign Institutional Review Board (IRB) approved study specific informed consent
Subject must voluntarily sign and date an informed consent, approved by an Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Willing to sign consent onto the Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking study, Institutional Review Board (IRB) number - (blood draw optional)
Patients must also provide written consent for biospecimens collection on Institutional Review Board (IRB) -
Written informed consent to participate in the study according to the investigational review board (IRB)
Must be fully informed regarding their illness and the investigational nature of the study protocol, and must sign an Institutional Review Board (IRB) approved Informed Consent Form (ICF).
Patients must sign the Institutional Review Board (IRB)-approved informed consent document for this trial
Be able to give written Institutional Review Board (IRB) approved informed consent and be able to follow protocol requirements
Patient is unwilling or unable to sign and date the Institutional Review Board (IRB) approved informed consent
Patients must voluntarily provide written Institutional Review Board (IRB)-approved informed consent
Sign an Institutional Review Board (IRB)-approved informed consent document
All patients must sign an Institutional Review Board (IRB)-approved informed consent document
Patients will sign an Institutional Review Board (IRB)-approved informed consent form prior to any study-related procedures
All patients must sign an Institutional Review Board (IRB)-approved informed consent document
Co-enrollment on Institutional Review Board (IRB) #, entitled Molecular Pathogenesis of Therapy-Related Leukemia, Dr. Armenian, principal investigator
Written informed consent and/or Consent waiver by institutional review board (IRB)
All patients must sign an institutional review board (IRB)-approved informed consent document
Subjects must give institutional review board (IRB)-approved study-specific informed consent
Written informed consent to participate in the study according to the Investigational Review Board (IRB)
Participants must sign the most current institutional review board (IRB)-approved study informed consent form (ICF)
Sign an institutional review board (IRB)-approved informed consent document
Optional participation in the microdose imaging trial, Institutional Review Board (IRB)#-
Patients or a legal guardian will sign an informed consent form approved by the Institutional Review Board (IRB) and obtained by the principal or a co-investigator before patient entry; minors will provide assent
Willing to sign an Institutional Review Board (IRB)-approved informed consent document and adhere to the protocol
Provide written informed consent for study participation, approved by the appropriate institutional review board (IRB), and be willing and able to cooperate with all aspects of the protocol;
Sign an Institutional Review Board (IRB)-approved informed consent document
Sign an Institutional Review Board (IRB)-approved informed consent document
Sign an Institutional Review Board (IRB)-approved informed consent document
All patients must sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Pennsylvania
Able to and provides Institutional Review Board (IRB) approved study specific written informed consent
Must be able and willing to sign an informed consent approved by the Institutional Review Board (IRB)
TNBC patients who are previously untreated and enrolled in the prospective Institutional Review Board (IRB) approved clinical trial: -
Consent: patients must be able to give written, informed consent as approved by the local Institutional Review Board (IRB)
Will sign the Institutional Review Board (IRB)-approved consent form
Women must be enrolled in Atlanta Womens human immunodeficiency virus (HIV) Interagency Study (WIHS) (institutional review board [IRB] # )
Patients must sign an Institutional Review Board (IRB)-approved informed consent document
Patients must sign an institutional review board (IRB)-approved informed consent document
Be Institutional Review Board (IRB)-approved and open to accrual at USC Norris
